Introduction
Shigellosis is an intestinal infection caused by bacteria in the genus Shigella. It primarily affects the large intestine, especially the colon, where the organisms invade the lining of the gut and trigger inflammation. The condition is defined by a combination of direct bacterial invasion, damage to intestinal epithelial cells, and a strong local immune response that disrupts normal fluid absorption and mucosal integrity.
Unlike many foodborne infections that remain confined to the gut lumen, Shigella has a distinctive ability to cross the intestinal surface, multiply inside cells, and spread from cell to cell. This intracellular lifestyle is central to the disease process. The illness develops when a small number of bacteria survive stomach acid, reach the intestine, and begin to interfere with the normal barrier function of the colonic mucosa. The result is an inflammatory infection of the bowel wall rather than a simple contamination of the intestinal contents.
The Body Structures or Systems Involved
Shigellosis involves several closely connected structures within the digestive system. The main site of disease is the colon, the final segment of the large intestine, although the rectum is often involved as well. The infection begins when bacteria enter the gastrointestinal tract and reach the mucosal surface that lines the intestine. This mucosa is made up of a single layer of epithelial cells covered by mucus and supported by immune cells, blood vessels, and connective tissue.
Under healthy conditions, the colonic epithelium acts as a barrier that separates the gut lumen from the internal environment of the body. Its cells absorb water and electrolytes, help form stool, and prevent microbial invasion. Tight junctions between cells limit leakage, while mucus and antimicrobial molecules help restrain harmful organisms. Beneath this lining, the gut-associated immune system monitors microbes and responds to threats without causing unnecessary tissue injury.
The infection also involves the immune system, especially innate immune cells such as neutrophils and macrophages. These cells are recruited into the intestinal wall during infection and are responsible for much of the inflammation and tissue damage seen in shigellosis. In addition, the infection influences local fluid and electrolyte handling in the bowel, which explains why the disease disrupts normal intestinal function.
How the Condition Develops
Shigellosis begins when a person ingests a relatively small number of Shigella bacteria, usually through contaminated hands, food, water, or direct contact with an infected person. The bacteria are unusually infectious because they can survive passage through the stomach in low doses and then reach the distal small intestine and colon. Once there, they interact with specialized epithelial cells and immune cells that sample material from the gut lumen.
A key step in the disease process is invasion through the intestinal epithelium. Shigella uses a specialized protein delivery system, often described as a type III secretion system, to inject bacterial proteins into host cells. These proteins manipulate the host cell’s internal machinery, allowing the bacteria to be taken up into the cell rather than destroyed. After entry, the bacteria escape from the engulfing vacuole into the cytoplasm, where they replicate.
Inside the host cell, Shigella exploits actin-based movement. It induces the host cell to polymerize actin around the bacterium, creating a propulsion system that helps the organism move through the cytoplasm and into neighboring cells. This cell-to-cell spread allows the bacteria to bypass some immune defenses that operate in extracellular spaces. The process is particularly important in the colon, where it causes focal areas of epithelial destruction and deepens inflammation.
The immune response contributes substantially to disease development. Infected epithelial cells and resident immune cells release inflammatory mediators that attract neutrophils into the intestinal wall and lumen. The migration of these cells through the epithelium increases tissue injury and disrupts the barrier. This response is aimed at limiting bacterial spread, but it also amplifies epithelial damage, mucus breakdown, and loss of normal absorptive function.
Shigella species also produce toxins and other virulence factors that intensify tissue injury. Some strains produce Shiga toxin or related toxins that interfere with protein synthesis in host cells and can worsen epithelial damage. Even when toxin production is limited, the combined effects of invasion, intracellular replication, and inflammatory signaling are enough to create significant disease.
Structural or Functional Changes Caused by the Condition
The main structural change in shigellosis is injury to the colonic mucosa. The epithelial lining becomes disrupted as bacteria invade, replicate, and spread laterally from cell to cell. This leads to cell death, surface erosion, and ulceration in more severe cases. The normally smooth barrier becomes patchy and inflamed, with loss of integrity at the level of the mucosa.
Inflammation alters the function of the bowel wall in several ways. First, it increases vascular permeability, allowing plasma proteins and fluid to leak into tissues and the intestinal lumen. Second, it recruits neutrophils, which release enzymes and reactive molecules that kill bacteria but also injure host cells. Third, it interferes with absorption of water and electrolytes by damaging epithelial transport processes and the absorptive surface itself.
The result is a colon that is less able to perform its normal roles of water conservation and stool formation. Instead of absorbing fluid efficiently, the inflamed mucosa can secrete or leak fluid into the lumen. Damaged epithelial cells and inflammatory exudate may mix with intestinal contents, and the mucosa’s ability to maintain a controlled barrier becomes impaired. These changes explain why shigellosis is more than a transient bacterial presence in the intestine: it is a structural inflammatory disease of the bowel lining.
In more intense infections, the inflammatory response can extend deeper into the bowel wall. This produces more extensive mucosal ulceration and greater disruption of local blood flow. The tissue then enters a cycle in which bacterial invasion, inflammatory injury, and impaired repair reinforce one another. Although the infection is usually limited to the intestine, the biochemical effects of inflammation can also influence systemic physiology, especially if the disease is severe.
Factors That Influence the Development of the Condition
The most important factor in shigellosis is exposure to the bacterium. Because the infectious dose is very low, transmission can occur even when contamination is slight. This makes person-to-person spread particularly efficient, especially where hand hygiene is limited or where fecal contamination of surfaces or food occurs. The biology of Shigella, rather than a broad environmental burden, explains why the condition can spread rapidly in close-contact settings.
Host defenses also shape whether infection develops. Stomach acid reduces the number of viable organisms that reach the intestine, so anything that lowers gastric acidity can increase susceptibility. The intestinal microbiome may also influence colonization, since a stable microbial community can compete with invading pathogens and help preserve mucosal resistance.
The immune system’s responsiveness is another determinant. A person with weakened mucosal immunity, impaired antibody responses, or malnutrition may be less able to contain bacterial invasion. Young children are often more susceptible because their immune defenses and barrier function are still developing, while individuals in crowded settings may encounter repeated exposure that overwhelms local defenses.
Shigella species and strains differ in virulence. Some carry more effective invasion systems, toxin genes, or mechanisms that evade immune clearance. These bacterial factors influence the degree of tissue invasion and the intensity of inflammatory signaling. Thus, the outcome depends on the interaction between microbial virulence, gastric survival, mucosal defense, and host immune response.
Variations or Forms of the Condition
Shigellosis can vary from a relatively limited intestinal infection to a more invasive inflammatory colitis. The exact form depends on the species or strain involved, the number of bacteria ingested, and the host response. Some infections remain confined to the mucosal surface and produce modest epithelial disruption, while others lead to widespread mucosal inflammation and ulceration.
There are also species-level differences. Shigella dysenteriae, Shigella flexneri, Shigella boydii, and Shigella sonnei differ in epidemiology and virulence. S. dysenteriae is classically associated with more severe disease because certain strains produce potent toxins. S. sonnei is often linked with milder illness in some settings, though it can still cause significant colitis.
The infection may also present as more acute or more prolonged depending on the balance between bacterial replication and immune control. In a rapidly contained infection, mucosal injury may be limited and recover quickly as epithelial cells regenerate. In more severe disease, continuing invasion and inflammation can produce deeper damage, more extensive ulceration, and a slower return to normal mucosal structure.
Another distinction is between localized intestinal disease and infections complicated by systemic effects. Shigellosis is primarily localized to the gut, but severe mucosal inflammation can trigger dehydration, electrolyte disturbance, and inflammatory stress beyond the bowel itself. These broader effects are secondary to intestinal pathology rather than signs of widespread bacterial dissemination in most cases.
How the Condition Affects the Body Over Time
The course of shigellosis depends on how quickly the host controls bacterial invasion and how much tissue injury occurs before that control is achieved. In uncomplicated cases, the intestinal epithelium regenerates after the infection is cleared. The colon has a strong capacity for repair because epithelial stem cells in the crypts can replace damaged surface cells. As the inflammatory stimulus resolves, mucosal architecture can return toward normal.
When infection is more severe or prolonged, the repeated cycle of invasion and inflammation can delay repair. Persistent epithelial damage may lead to continued leakage of fluid, mucus, and inflammatory cells into the lumen. The bowel wall can remain hypersensitive and dysfunctional for a period even after the bacteria are controlled, reflecting temporary disruption of mucosal integrity and local immune activation.
Complications arise from the same basic mechanisms that define the disease. Extensive inflammation can deepen ulceration and increase the risk of significant fluid loss. In some strains, toxin-mediated injury can contribute to more serious tissue and vascular damage. If the inflammatory response is intense, the body may also experience systemic consequences from cytokine release and metabolic stress, though the infection remains centered in the intestine.
Over time, the body attempts to restore barrier function by replacing damaged epithelial cells, reducing inflammatory signaling, and reestablishing tight junctions and mucus production. The speed and completeness of this process vary according to the severity of initial injury and the effectiveness of host defense. Shigellosis therefore illustrates a dynamic interaction between microbial invasion and mucosal repair, in which disease reflects both direct bacterial activity and the body’s response to it.
Conclusion
Shigellosis is an inflammatory infection of the colon caused by Shigella bacteria. Its defining features are low-dose transmission, invasion of the intestinal epithelium, intracellular replication, and spread from cell to cell. These processes damage the mucosal barrier and provoke a strong immune response that alters the structure and function of the bowel lining.
Understanding shigellosis requires attention to both the microorganism and the tissue it targets. The disease develops not merely from the presence of bacteria in the gut, but from their ability to breach epithelial defenses, manipulate host cells, and trigger inflammation that disrupts normal intestinal physiology. That combination of invasion, immune activation, and epithelial injury is what makes shigellosis a distinct form of bacterial colitis.